Azelis Group NV: history, ownership, mission, how it works & makes money

Azelis Group NV: history, ownership, mission, how it works & makes money

BE | Basic Materials | Chemicals - Specialty | EURONEXT

Azelis Group NV (AZE.BR) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



A Brief History of Azelis Group NV

Azelis Group NV, founded in 2001, is a leading specialty chemicals and food ingredients distributor headquartered in Antwerp, Belgium. The company has built a significant presence in Europe, Asia, the Middle East, and Africa, providing innovative solutions to its customers.

In 2016, Azelis underwent a major transformation, which included the acquisition of the specialty chemicals distributor, the Italian company A.M.A. This acquisition strengthened its position in the personal care sector, adding new suppliers and product lines.

By 2018, Azelis had expanded its footprint through strategic acquisitions, including the purchase of the French company, Quimdis, which enhanced its capabilities in the life sciences sector. This deal allowed Azelis to offer a broader portfolio of ingredients and formulations.

The company went public in September 2020, listing on the Euronext Brussels under the ticker AZE. The IPO was well-received, raising approximately €1 billion. This capital raised was aimed at accelerating growth through further acquisitions and strengthening its operational capabilities.

Year Event Financial Impact
2001 Founded in Antwerp, Belgium -
2016 Acquisition of A.M.A (Italy) Increased presence in personal care sector
2018 Acquisition of Quimdis (France) Expanded life sciences portfolio
2020 IPO on Euronext Brussels Raised approximately €1 billion

In the fiscal year 2022, Azelis reported revenue of approximately €2.5 billion, reflecting a year-on-year growth of 12%. This growth was driven by strong demand in the life sciences and industrial segments.

As of 2023, Azelis has over 2,600 employees and operates in more than 58 countries. The company serves diverse markets including chemicals, food, health, and beauty. Its commitment to sustainability and innovation is evident in its ongoing investments in eco-friendly product lines and solutions.

Throughout its history, Azelis has focused on building strategic partnerships with leading suppliers in various sectors. This approach has enabled the company to offer tailored solutions to its customers and maintain a competitive edge in the rapidly evolving specialty chemicals market.



A Who Owns Azelis Group NV

Azelis Group NV, a leading distributor of specialty chemicals and food ingredients, operates under the ownership of various private equity firms and institutional investors. As of the latest data in October 2023, Azelis is primarily owned by EQT and the Abu Dhabi Investment Authority (ADIA). EQT acquired a significant stake in the company in 2018, enabling strategic growth and expansion.

Shareholder Ownership Percentage Stake Acquired Investment Date
EQT 60% Majority Stake 2018
Abu Dhabi Investment Authority (ADIA) 20% Minority Stake 2020
Other Institutional Investors 20% Various Ongoing

Azelis went public in 2021 through an initial public offering (IPO), further distributing its shares to a broader range of institutional and retail investors. The IPO was priced at €16.50 per share, allowing the company to raise approximately €1.3 billion. This funding facilitated several acquisitions within the specialty chemicals sector, enhancing their market penetration.

According to the company’s financial reports for Q2 2023, Azelis reported a revenue of €1.7 billion, reflecting a year-on-year growth of 15%. The adjusted EBITDA stood at €300 million, with a margin of 17.6%.

Azelis operates through a decentralized model, providing tailored solutions across various industries including pharmaceuticals, food and nutrition, and industrial chemicals. The company has over 2,600 employees and operates in more than 56 countries, further increasing its global footprint.

The following table highlights Azelis’s market performance since its IPO:

Year Stock Price (€) Market Capitalization (€ Billion) Revenue (€ Billion)
2021 16.50 2.1 1.3
2022 19.00 2.4 1.5
2023 20.50 2.7 1.7

Current estimates suggest that Azelis continues to dominate the chemical distribution market, with a projected growth rate of 7% CAGR through 2025. The company's strategic partnerships and consistent focus on innovation have further solidified its position as a key player in the industry.



Azelis Group NV Mission Statement

Azelis Group NV, a leading distributor of specialty chemicals and food ingredients, articulates its mission through a clear statement focused on innovation, sustainability, and customer-centric solutions. The company aims to deliver value across various sectors, including pharmaceuticals, personal care, and agrochemicals, by leveraging its extensive technical expertise and global network.

The core components of Azelis' mission statement emphasize:

  • Providing innovative solutions tailored to customer needs.
  • Driving sustainability in operations and supply chains.
  • Building long-lasting partnerships with suppliers and customers.
  • Investing in employee development and operational excellence.

The company is committed to enhancing the value chain for its stakeholders through its comprehensive product portfolio and technical support. This strategic focus allows Azelis to maintain a competitive edge in the market.

Financial Overview

The financial performance of Azelis Group NV demonstrates its commitment to achieving its mission. The company reported significant growth in revenues and net profit figures for the fiscal year 2022.

Financial Metric 2022 Amount (in million EUR) 2021 Amount (in million EUR) Year-over-Year Growth
Revenue 3,250 2,660 22.1%
EBITDA 365 305 19.7%
Net Profit 200 165 21.2%
Total Assets 1,800 1,500 20.0%
Employees 2,600 2,200 18.2%

This financial data underscores the effectiveness of Azelis' strategy in fulfilling its mission. The consistent revenue growth indicates strong demand for specialty chemicals and food ingredients, while the increase in net profit reflects effective cost management and operational efficiencies.

In addition to financial metrics, Azelis also places a strong emphasis on sustainability. The company has set goals to reduce carbon emissions by 30% by 2025 and aims for 50% of its product portfolio to be sustainable by 2030, aligning its mission with global sustainability goals.

Through its mission statement, Azelis Group NV not only defines its operational priorities but also highlights its commitment to fostering innovation and sustainable practices in the specialty chemical industry. The solid financial foundation and proactive goals for sustainability are integral to achieving this mission.



How Azelis Group NV Works

Azelis Group NV is a global leader in the distribution of specialty chemicals and food ingredients. The company's operational model is centered around providing tailored solutions and value-added services to its customers across various industries, including pharmaceuticals, food, personal care, agriculture, and coatings.

The company operates through a network of over 60 countries, with more than 2,300 employees. Azelis focuses on a customer-centric approach, leveraging its technical expertise to offer customized solutions and formulations. This strategy allows the company to maintain strong relationships with both suppliers and customers.

Azelis is structured into different business segments, including:

  • Specialty Chemicals
  • Food Ingredients
  • Pharmaceutical Ingredients
  • Personal Care
  • Agricultural Solutions

In 2022, Azelis reported revenue of approximately €2.1 billion, representing an increase of around 29% compared to the previous year. This growth was driven by strong demand across various sectors, particularly in food and pharmaceuticals.

The operating income for 2022 was recorded at €210 million, yielding an operating margin of approximately 10%. The company's EBITDA for the same period stood at about €275 million, reflecting an EBITDA margin of around 13%.

Financial Year Revenue (€ million) Operating Income (€ million) EBITDA (€ million) Operating Margin (%) EBITDA Margin (%)
2020 €1,500 €120 €160 8% 10.7%
2021 €1,600 €150 €200 9.4% 12.5%
2022 €2,100 €210 €275 10% 13%

Furthermore, Azelis emphasizes sustainability and innovation throughout its operations. The company has implemented eco-friendly practices and actively seeks to provide sustainable product alternatives to its clients. In 2021, Azelis launched a new range of sustainable products, which accounted for approximately 25% of total sales by 2022.

Azelis's supply chain management is robust, facilitating efficient procurement and distribution processes. The company utilizes advanced technology and data analytics to optimize inventory management and demand forecasting, ensuring responsiveness to market changes.

Furthermore, Azelis maintains strategic partnerships with key manufacturers, enhancing its supplier network. By collaborating closely with suppliers, the company can offer exclusive products and formulations that cater to specific customer needs.

In terms of capital investments, Azelis has committed over €50 million towards expanding its facilities and enhancing operational capabilities in the last fiscal year. This investment is aimed at bolstering its production and logistics infrastructure to support ongoing business growth.

Azelis has also prioritized digital transformation initiatives, incorporating advanced digital tools to enhance customer engagement and streamline internal operations. The company has reported a significant increase in online order volumes, with digital sales representing approximately 30% of total sales as of 2022.

In summary, Azelis Group NV's operational framework integrates a customer-focused approach, strong supplier relationships, and a commitment to sustainability and digital innovation, positioning the company for continued growth in the specialty chemicals and food ingredients sectors.



How Azelis Group NV Makes Money

Azelis Group NV is a leading global distributor of specialty chemicals and food ingredients. The company operates in several sectors, including personal care, pharmaceuticals, food and nutrition, and agriculture. Its revenue generation is primarily based on a combination of distribution services and value-added solutions offered to its customers.

In 2022, Azelis reported a revenue of approximately €2.9 billion, reflecting an increase of around 22% from the previous year. This growth was driven by strategic acquisitions and an expanded product offering across various market segments.

Revenue Streams

  • Distribution Services: Azelis acts as a middleman, sourcing specialty chemicals and ingredients from manufacturers and distributing them to various industries.
  • Value-Added Solutions: The company provides formulation development, regulatory compliance support, and logistical services to enhance the value of its offerings.

Key Financial Highlights

According to its last earnings report, Azelis achieved the following key financial metrics:

Metric 2022 2021
Total Revenue €2.9 billion €2.4 billion
Net Profit €137 million €104 million
EBITDA €280 million €228 million
Gross Margin 20% 21%

Azelis’ diverse portfolio allows it to mitigate risks associated with market fluctuations. By serving multiple industries, the company can capitalize on growth areas such as health and nutrition, which has seen an increasing demand.

Market Segments

Azelis operates in various market segments, contributing to its revenue as follows:

Market Segment Percentage of Total Revenue (2022)
Personal Care 26%
Pharmaceuticals 18%
Food & Nutrition 22%
Agriculture 16%
Industrial Chemicals 18%

In terms of geographical reach, Azelis generates significant revenues from Europe, accounting for approximately 70% of its total revenue, with the remaining coming from Asia-Pacific, the Americas, and the Middle East.

Strategic Acquisitions

Azelis has actively pursued acquisitions to expand its market presence and capabilities. Notable recent acquisitions include:

  • Acquisition of Gadot Biochemical Industries in 2022, enhancing its capabilities in food ingredients.
  • Acquisition of G. H. Phipps Company in 2021, increasing its footprint in the specialty chemicals market.

Outlook and Growth Potential

Looking ahead, Azelis aims for continued expansion through both organic growth and further acquisitions. Analysts predict that the specialty chemicals market is expected to grow at a CAGR of 5.3% between 2023 and 2028, providing ample opportunity for Azelis to enhance its revenue streams.

The company also emphasizes sustainability, aligning its products and services with environmental regulations and consumer preferences, which positions it favorably within various markets seeking eco-friendly solutions.

Azelis’s focus on technological advancement, digital transformation, and customer-centric strategies further supports its revenue generation capabilities, making it a significant player in the global distribution of specialty chemicals and food ingredients.

DCF model

Azelis Group NV (AZE.BR) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.